Market access tech Access Infinity combines consulting with proprietary digital tools (Access Hub, NURO, Evidence Library) to streamline market access and pricing decisions for pharma. This presents a sales opportunity to upsell or cross-sell expanded tool usage, data integrations, and premium analytics for larger portfolios.

AI powered expansion Recent announcements of AI-powered solutions indicate a strategic shift toward automation and advanced analytics. This creates a chance to position additional AI modules, customization, and support services to accelerate decision making for pharma clients seeking faster insights.

Global footprint With projects completed in over 40 countries and a client base comprising leading pharma and biotech firms, there is a proven ability to scale solutions across regions. Target multi-region pharma teams with bundled deployments, regional data harmonization, and cross-country KPI tracking.

Evidence collaboration Evidence Library enables centralized storage and collaboration on HEOR projects. This presents sales potential for expanding to full evidence generation programs, publication management, and integrated workflows for larger teams or new indications.

Financial growth signals Mid-market revenue range indicates sizable yet still addressable market potential. Engage growth-minded pharma companies seeking to professionalize market access functions, offering tiered service plans, training, and managed services to drive higher contract values.